Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Total Current Liabilities (2016 - 2025)

AC Immune (ACIU) has disclosed Total Current Liabilities for 9 consecutive years, with $115.1 million as the latest value for Q4 2024.

  • On a quarterly basis, Total Current Liabilities rose 652.1% to $115.1 million in Q4 2024 year-over-year; TTM through Dec 2024 was $115.1 million, a 652.1% increase, with the full-year FY2024 number at $115.1 million, up 661.5% from a year prior.
  • Total Current Liabilities was $115.1 million for Q4 2024 at AC Immune, up from $15.3 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $115.1 million in Q4 2024 to a low of $11.9 million in Q4 2022.
  • A 5-year average of $35.9 million and a median of $15.5 million in 2020 define the central range for Total Current Liabilities.
  • Peak YoY movement for Total Current Liabilities: tumbled 45.13% in 2022, then soared 652.1% in 2024.
  • AC Immune's Total Current Liabilities stood at $15.5 million in 2020, then skyrocketed by 40.06% to $21.7 million in 2021, then crashed by 45.13% to $11.9 million in 2022, then rose by 28.42% to $15.3 million in 2023, then skyrocketed by 652.1% to $115.1 million in 2024.
  • Per Business Quant, the three most recent readings for ACIU's Total Current Liabilities are $115.1 million (Q4 2024), $15.3 million (Q4 2023), and $11.9 million (Q4 2022).